MyraMMizokamiMD

PubMed

• 2 citations
  Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated d...
  Bindu Kanathezhath, Myra Mizokami, Sharleny Stanislaus, Catherine Hounshell, Lynne Neumayr, Hua Guo, John E. Hearst, Mark C. Walters, Frans A. Kuypers> ;Experimental Biology and Medicine. 2011 Apr 1
• 25 citations
  Chimeric TNT-3 Antibody/Murine Interferon-γ Fusion Protein for the Immunotherapy of Solid Malignancies
  Myra M. Mizokami, Peisheng Hu, Leslie A. Khawli, Jiali Li, Alan L. Epstein> ;Hybridoma and Hybridomics. 2003 Aug 1
• 34 citations
  Identification of a protein fragment of interleukin 2 responsible for vasopermeability.
  Alan L. Epstein, Myra M. Mizokami, Jiali Li, Peisheng Hu, Leslie A. Khawli> ;Journal of the National Cancer Institute. 2003 May 21
• 29 citations
  Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity
  Peisheng Hu, Myra M. Mizokami, Gina Ruoff, Leslie A. Khawli, Alan L. Epstein> ;Blood. 2003 Jun 15
• 38 citations
  Pharmacokinetic Characteristics and Biodistribution of Radioiodinated Chimeric TNT-1, -2, and -3 Monoclonal Antibodies After Chemical Modification with Biotin
  Leslie A. Khawli, Myra M. Mizokami, Jahangir Sharifi, Peisheng Hu, Alan L. Epstein> ;Cancer Biotherapy & Radiopharmaceuticals. 2002 Aug 1
• 29 citations
  Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.
  Jason L. Hornick, Jahangir Sharifi, Leslie A. Khawli, Peisheng Hu, Wei Guo Bai, Mian M. Alauddin, Myra M. Mizokami, Alan L. Epstein> ;Journal of Nuclear Medicine. 2000 Feb 1
• 52 citations
  A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors.
  Jason L. Hornick, Jahangir Sharifi, Leslie A. Khawli, Peisheng Hu, Barbara H. Biela, Myra M. Mizokami, Aoyun Yun, Clive R. Taylor, Alan L. Epstein> ;Cancer Biotherapy & Radiopharmaceuticals. 1998 Jan 1
• Join now to see all